logo
Select company
Select metric
$ 2.4MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
36
Sector
75
Industry
57
History
23
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

STRR1

Company Name

STAR EQUITY HOLDINGS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

STAR EQUITY HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STRR1 - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 5.96M$ -3.56M$ 2.4M
3/31/2025$ 5.65M$ -11.59M$ -5.94M
12/31/2024$ 4.77M$ -10.81M$ -6.04M
9/30/2024$ 3.82M$ -8.16M$ -4.34M
6/30/2024$ 3.34M$ -9.02M$ -5.68M
3/31/2024$ 2.92M$ 20.52M$ 23.44M
12/31/2023$ 3.33M$ 23.55M$ 26.87M
9/30/2023$ 3.83M$ 25.37M$ 29.2M
6/30/2023$ 4.11M$ 26.19M$ 30.3M
3/31/2023$ 4.85M$ -912K$ 3.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STAR EQUITY HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ 3.92M.
  • Over the past 5 years, STAR EQUITY HOLDINGS INC's average EBITDA has been $ 6.21M.
  • The median EBITDA for STAR EQUITY HOLDINGS INC during this period was $ 3.42M
  • STAR EQUITY HOLDINGS INC reached its highest EBITDA over the past 5 years at $ 30.3M.
  • The lowest EBITDA recorded by STAR EQUITY HOLDINGS INC in the same timeframe $ -6.04M

STAR EQUITY HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
XWEL : XWELL INC $ -17.19MBIAF : BIOAFFINITY TECHNOLOGIES INC $ -11MSRXH : SRX HEALTH SOLUTIONS INC $ -13.87MISPC : ISPECIMEN INC $ -8.26MVERO : VENUS CONCEPT INC $ -32.23MSSKN : STRATA SKIN SCIENCES INC $ -4.44MSBFM : SUNSHINE BIOPHARMA INC $ -6.19MFLGC : FLORA GROWTH CORP $ -12.18MADVB : ADVANCED BIOMED INC $ -2.92MBNBX : APPLIED DNA SCIENCES INC $ -12.85M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for STAR EQUITY HOLDINGS INC is calculated as follows: EBIT [ $ -4.73M ] + DepAmor [ $ 8.65M ]
(=) EBITDA [ $ 3.92M ]

STRR1 - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -6.04M

Minimum

Dec 31, 2024

$ 30.3M

Maximum

Jun 30, 2023

$ 6.21M

Average

$ 3.42M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M